Filgotinib Promising for RA
FDA Approves Rituximab Biosimilar; Plus New Safety Data for Filgotinib in RA Patients
Zilretta Promising for Blood Glucose Levels; Plus Filgotinib Promising for RA
- Connect with us:
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
ACR/ARP Annual Meeting
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
American College of Rheumatology
Visit the official website for the American College of Rheumatology.